China Resources Double-Crane Pharmaceutical Co.,Ltd. Stock
Stocks
600062
CNE000000Q94
Pharmaceuticals
|
End-of-day quote
Shanghai S.E.
2026-08-17
|
5-day change | 1st Jan Change | ||
| 16.06 CNY | +0.37% |
|
-2.07% | -12.19% |
| 08-14 | CR Double-Crane Pharma Gets China Nod for Irrigation Solution | MT |
| 08-13 | CR Double-Crane Pharma's Unit Gets Nod for DC7001A Capsules Clinical Trial | MT |
| Market Cap | 16.59B 2.46B 2.12B 1.99B 1.82B 3.41B 235B 3.46B 23.36B 9.15B 118B 9.24B 9.04B 392B | P/E 2026 * |
9.47x | P/E 2027 * | 8.9x |
|---|---|---|---|---|---|
| Enterprise Value | 16.59B 2.46B 2.12B 1.99B 1.82B 3.41B 235B 3.46B 23.36B 9.15B 118B 9.24B 9.04B 392B | EV / Sales 2026 * |
1.43x | EV / Sales 2027 * | 1.36x |
| Free-Float |
37.82% | Yield 2026 * |
3.18% | Yield 2027 * | 3.3% |
| 1 day | +0.37% | ||
| 1 week | -2.07% | ||
| Current month | -1.29% | ||
| 1 month | -5.14% | ||
| 3 months | -8.65% | ||
| 6 months | -12.29% | ||
| Current year | -12.19% |
| 1 week | 15.68 |  | 16.58 |
| 1 month | 15.68 | | 17.55 |
| Current year | 15.29 | | 19.08 |
| 1 year | 15.29 | | 20.7 |
| 3 years | 14.8 | | 26.15 |
| 5 years | 11.1 | | 37.44 |
| 10 years | 10.66 | | 37.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wen Hao Huang
DFI | Director of Finance/CFO | 43 | 2025-02-17 |
Qian Zhao
PSD | President | 45 | 2024-10-24 |
Li Hong Zheng
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Mao Zhu Sun
BRD | Director/Board Member | 67 | 2021-07-11 |
Ning Liu
BRD | Director/Board Member | 68 | 2006-05-29 |
Wen Chao Lu
CHM | Chairman | 50 | 2023-09-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/21/22 | Buy | Chairman | 5,000 | 0.0005% | ||
| 12/21/22 | Buy | Director | 10,000 | 0.0010% | ||
| 12/20/22 | Buy | Director | 5,000 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.37% | -2.07% | -21.39% | -2.73% | 2.45B | |
| +0.25% | -3.96% | +68.73% | +120.06% | 1,052B | |
| +0.78% | +0.21% | +48.53% | +50.78% | 627B | |
| +0.35% | +0.95% | +21.11% | +66.86% | 441B | |
| +0.28% | -4.56% | +39.10% | +38.05% | 349B | |
| +0.78% | -2.68% | +24.03% | +37.32% | 287B | |
| +0.87% | -3.59% | -0.28% | +7.12% | 241B | |
| +1.00% | +0.52% | +41.46% | +58.95% | 224B | |
| -0.78% | -4.49% | -10.28% | -54.13% | 202B | |
| +0.40% | +4.40% | +17.36% | +81.59% | 172B | |
| Average | +0.43% | -1.27% | +22.84% | +40.39% | 359.76B | |
| Weighted average by Cap. | +0.44% | -1.70% | +39.67% | +63.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 11.59B 1.72B 1.48B 1.39B 1.27B 2.39B 164B 2.42B 16.33B 6.4B 82.37B 6.46B 6.32B 274B | 12.18B 1.81B 1.56B 1.46B 1.33B 2.51B 173B 2.54B 17.15B 6.72B 86.55B 6.78B 6.64B 288B |
| Net income | 1.76B 261M 225M 211M 192M 362M 24.92B 367M 2.47B 970M 12.49B 979M 957M 41.53B | 1.87B 278M 240M 225M 205M 385M 26.57B 391M 2.64B 1.03B 13.31B 1.04B 1.02B 44.27B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-17 | CN¥16.06 | +0.37% | 10,377,998 |
| 26-08-14 | CN¥16.00 | -2.56% | 13,916,731 |
| 26-08-13 | CN¥16.42 | +0.18% | 14,832,300 |
| 26-08-12 | CN¥16.39 | +0.06% | 8,489,764 |
| 26-08-11 | CN¥16.38 | -0.12% | 14,314,102 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600062 Stock
Select your edition
All financial news and data tailored to specific country editions
